On the other hand, as a serial acquirer, if Valeant simply adds Medicis, and then looks for its next deal without taking care to truly integrate Medicis and manage it well, this could turn out to be a benefit to competitors like Allergan.

FORBES: Valeant To Acquire Medicis for $2.6 Billion

Lingering skepticism about the future and distrust in financial brands, coupled with confusion over where to turn for such needs can often cause people to tune out and turn away from the very products that serve to benefit them down the road.

FORBES: Behind The Brand: Why The Principal Is Encouraging People To 'Dream Again'

The real benefit here will turn out to be in improving the efficiency of the health care system, reducing waits and endlessly repeated forms.

FORBES: Magazine Article